Luqa Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$104M
- Investors
-
3
Luqa Pharmaceuticals General Information
Description
Developer of dermatology products in the medical aesthetic industry. The company aims to provide patients with skincare products prescribed by physicians and dermatologists to achieve clear, radiant skin.
Contact Information
Primary Office
- Room E, 8th Floor
- No. 888 Wanhangdu Road, Jing'an District
- Shanghai
- China
Luqa Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Feb-2021 | $104M | 0000 | 00000 | Completed | Generating Revenue |
| 2. Later Stage VC (Series B) | 06-Apr-2018 | 0000 | 0000 | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 09-Jun-2015 | $15M | $15M | Completed | Generating Revenue |
Luqa Pharmaceuticals Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Luis Juste | Director, Business Development | ||
| Jordi Paradis Ph.D | Director, Finance & Administration |
Luqa Pharmaceuticals Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hugo Peris | Self | Board Member | 000 0000 |
| Jun Wu Ph.D | Cenova Capital | Board Member | 000 0000 |
| Tim Xiao | Delos Capital Partners | Board Member | 000 0000 |
| Ula Xue | Delos Capital Partners | Board Observer | 000 0000 |